Booth Bruce
Kymera Therapeutics, Inc. · Director
Booth Bruce is listed in filings as Director at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR), Vigil Neuroscience, Inc. (VIGL), and Sionna Therapeutics, Inc. (SION). The current snapshot covers public activity from Aug 5, 2025 to Jun 25, 2026. Reported amounts are shown as $313.8K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.